Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM1A | O60341 | 16/20 | 0.53 |
| ▸ | MAOA | P21397 | 15/20 | 0.53 |
| ▸ | MAOB | P27338 | 15/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21066062 | 1.00 | KDM1A (0.53) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| SCHEMBL21066065 | 1.00 | KDM1A (0.53) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| SCHEMBL8041609 | 1.00 | KDM1A (0.53) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| SCHEMBL2766130 | 1.00 | KDM1A (0.53) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| SCHEMBL4739718 | 1.00 | KDM1A (0.53) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| Hydrochloric Acid SCHEMBL28632580 | 0.98 | KDM1A (0.55) | KDM1AMAOAMAOB | |
| Hydrochloric Acid SCHEMBL2073275 | 0.98 | KDM1A (0.55) | KDM1AMAOAMAOB | |
| Trifluoroacetic Acid SCHEMBL14762539 | 0.90 | KDM1A (0.44) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| Trifluoroacetic Acid SCHEMBL13722853 | 0.90 | KDM1A (0.44) | KDM1AMAOAMAOBMAPK1CYP2C19 | |
| SCHEMBL901505 | 0.86 | KDM1A (0.52) | KDM1AMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 380 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240092849-A1 | SELECTIVE MCL-1 BINDING PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-03-21 | — | — | US | claimed |
| CN-113372235-B | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acids | 佛山奕安赛医药科技有限公司 | 2022-08-19 | — | — | CN | claimed |
| CN-113372235-A | Process for preparing 1-amino-2-phenylcyclopropanecarboxylic acid | 佛山奕安赛医药科技有限公司 | 2021-09-10 | — | — | CN | claimed |
| US-20190077840-A1 | SELECTIVE MCL-1 BINDING PEPTIDES | NATIONAL INSTITUTES OF HEALTH | 2019-03-14 | — | — | US | claimed |
| WO-2017075349-A2 | SELECTIVE MCL-1 BINDING PEPTIDES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-05-04 | — | — | WO | claimed |
| US-20160213742-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2016-07-28 | — | — | US | claimed |
| WO-2015164289-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2015-10-29 | — | — | WO | claimed |
| WO-2015035102-A2 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | CIDARA THERAPEUTICS, INC. (US) | 2015-03-12 | — | — | WO | claimed |
| EP-0135429-B1 | THE SYNTHESIS OF CYCLOPROPANE AMINO ACIDS AND PEPTIDES | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1992-03-18 | — | — | EP | claimed |
| EP-4745152-A2 | PEPTIDES BINDING TO BFL-1 | Dana-Farber Cancer Institute, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3341008-B1 | PEPTIDES BINDING TO BFL-1 | DANA FARBER CANCER INST INC (US) | 2026-04-15 | — | — | EP | disclosed |
| US-12570698-B2 | Stabilized peptides for covalent binding to target protein | DANA-FARBER CANCER INSTITUTE, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-12552834-B2 | Selective MENA binding peptides | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2026-02-17 | — | — | US | disclosed |
| US-20260035421-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3 | UNIV CHICAGO (US) | 2026-02-05 | — | — | US | disclosed |
| US-4954158-A | INHIBIT ETHYLENE PRODUCTION IN PLANTS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1990-09-04 | — | — | US | disclosed |
| WO-1990007260-A2 | 2,3-METHANOPROLINE | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1990-07-12 | — | — | WO | disclosed |
| EP-0349570-A1 | RENIN INHIBITORS CONTAINING A CYCLOPROPYL AMINO ACID AND/OR A CYCLOALKYL TRANSITION-STATE ANALOGUE | THE UPJOHN COMPANY (US) | 1990-01-10 | — | — | EP | disclosed |
| WO-1988007053-A1 | RENIN INHIBITORS CONTAINING A CYCLOPROPYL AMINO ACID AND/OR A CYCLOALKYL TRANSITION-STATE ANALOGUE | THE UPJOHN COMPANY (US) | 1988-09-22 | — | — | WO | disclosed |
| EP-0135429-A1 | The synthesis of cyclopropane amino acids and peptides | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1985-03-27 | — | — | EP | disclosed |
| WO-1985000809-A1 | THE SYNTHESIS OF CYCLOPROPANE AMINO ACIDS AND PEPTIDES | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 1985-02-28 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190077840-A1 | SELECTIVE MCL-1 BINDING PEPTIDES | MCL1, BCL2L11, BCL2L1 | KDM1A 4352/4885MAOA 4849/4885MAOB 4789/4885 |
| US-20240092849-A1 | SELECTIVE MCL-1 BINDING PEPTIDES | MCL1, BCL2L11, BCL2L1 | KDM1A 4352/4885MAOA 4849/4885MAOB 4789/4885 |
| US-12570698-B2 | Stabilized peptides for covalent binding to target protein | STUB1, JMJD7, PTMS | KDM1A 374/4885MAOA 4822/4885MAOB 4764/4885 |
| US-20260035421-A1 | COMPOSITIONS AND METHODS FOR INHIBITION OF FOXP3 | FOXO3, YBX3, FOXO1 | KDM1A 727/4885MAOA 4210/4885MAOB 4496/4885 |
| US-20160213742-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FUNGAL INFECTIONS | FPR1, FPR3, FPR2 | KDM1A 4155/4885MAOA 2387/4885MAOB 1935/4885 |
| US-12552834-B2 | Selective MENA binding peptides | VASP, MEN1, RBM25 | KDM1A 4070/4885MAOA 4024/4885MAOB 4594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.